Regression of Coronary Atherosclerosis in Heterozygous Familial Hypercholesterolemia IIa by the Therapy of Plasmapheresis and Hypolipidemic Drugs

The Journal of Japan Atherosclerosis Society
doi 10.5551/jat1973.16.4_473
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Atherosclerosis Society

Related search

Characterization of Atherosclerosis Formation in a Murine Model of Type IIa Human Familial Hypercholesterolemia

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Difference in the Risk Factors for Coronary, Renal and Other Peripheral Arteriosclerosis in Heterozygous Familial Hypercholesterolemia

Circulation Journal
MedicineCardiovascular MedicineCardiology
2004English

Cardio-Ankle Vascular Index in Heterozygous Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2012English

Carotid and Aortic Stiffness in Patients With Heterozygous Familial Hypercholesterolemia

Artery Research
2011English

Hypolipidemic Therapy by Statins in Acute Coronary Syndrome

Siberian Medical Review
2018English

Apolipoprotein E Polymorphism and Heterozygous Familial Hypercholesterolemia. Sex-Specific Effects

Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
1994English

Risk Factors Affecting the Phenotypic Expression of Heterozygous Familial Hypercholesterolemia in Pakistani Population

Atlas Journal of Biology
2010English

Angiotensin-Converting Enzyme DD Genotype and Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

Pcv38 - Budget Impact of Alirocumab in the Management of Heterozygous Familial Hypercholesterolemia Patients in Argentina

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy